Protective effect of berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver

被引：66

作者：

Zhou, Ji-Yin ^{[1
]}

Zhou, Shi-Wen ^{[1
]}

机构：

[1] Third Mil Med Univ, Xinqiao Hosp, Base Drug Clin Trial, Chongqing 400037, Peoples R China

来源：

FITOTERAPIA | 2011年 / 82卷 / 02期

关键词：

Berberine; Positive transcription elongation factor b; Antioxidant; Lipid peroxidation; Diabetes; Liver tissue; P-TEFB; METABOLISM; DIET; HYPERLIPIDEMIA; MECHANISM; APOPTOSIS; MELLITUS; IMPROVES; INSULIN;

D O I：

10.1016/j.fitote.2010.08.019

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The protective effect of berberine against antioxidant, antilipid peroxidation in serum and liver tissue, and positive transcription elongation factor b (P-TEFb) expression in liver tissue of type 2 diabetic rats was investigated. Overnight fasted rats were intraperitoneally injected 35 mg/kg streptozotocin. Diabetic rats were admitted after 2 weeks and given a high-carbohydrate/high-fat diet to induce hyperlipidemias. From week 16, diabetic rats were treated with 75, 150, 300 mg/kg berberine, 100 mg/kg fenofibrate or 4 mg/kg rosiglitazone for another 16 weeks. P-TEFb (composed of cyclin-dependent kinase 9 and cyclin T1) mRNA and protein expression in liver tissue were detected by real time PCR and immunohistochemistry, respectively. Berberine significantly up-regulated the declined cyclin-dependent kinase 9, cyclin T1 mRNA and protein expression in diabetic rat liver. Berberine obviously decreased malondialdehyde level and increased catalase, superoxide dismutase, glutathione peroxidase, and glutathione activities in liver tissue and serum of diabetic rats. These results suggest that the effects of berberine on up-regulation of P-TEFb expression, antioxidant and antilipid peroxidation may be related to its protective potential on diabetes. (C) 2010 Elsevier B.V. All rights reserved.

引用

页码：184 / 189

页数：6

共 26 条

[1] An update on the etiology and epidemiology of diabetes mellitus [J].

Adeghate, Ernest ;

Schattner, Peter ;

Dunn, Earl .

DIABETES MELLITUS AND ITS COMPLICATIONS: MOLECULAR MECHANISMS, EPIDEMIOLOGY, AND CLINICAL MEDICINE, 2006, 1084 :1-29

[2] The cardiovascular safety of rosiglitazone [J].

Ajjan, Ramzi A. ;

Grant, Peter J. .

EXPERT OPINION ON DRUG SAFETY, 2008, 7 (04) :367-376

[3] Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo [J].

Chao, SH ;

Price, DH .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) :31793-31799

[4]

Drewa Gerard, 2002, Med Sci Monit, V8, pBR338

[5] Regulation of transcription by proteins that control the cell cycle [J].

Dynlacht, BD .

NATURE, 1997, 389 (6647) :149-152

[6]

Filippatos T, 2008, EXPERT OPIN INV DRUG, V17, P1599, DOI [10.1517/13543784.17.10.1599, 10.1517/13543784.17.10.1599 ]

[7] Decreased apoptosis as a mechanism for hepatomegaly in streptozotocin-induced diabetic rats [J].

Herrman, CE ;

Sanders, RA ;

Klaunig, JE ;

Schwarz, LR ;

Watkins, JB .

TOXICOLOGICAL SCIENCES, 1999, 50 (01) :146-151

[8] Cornuside Attenuates Apoptosis and Ameliorates Mitochondrial Energy Metabolism in Rat Cortical Neurons [J].

Jiang, Wang-Lin ;

Chen, Xi-Guang ;

Zhu, Hai-Bo ;

Hou, Jian ;

Tian, Jing-Wei .

PHARMACOLOGY, 2009, 84 (03) :162-170

[9] Inhibitory Activities of the Alkaloids from Coptidis Rhizoma against Aldose Reductase [J].

Jung, Hyun Ah ;

Yoon, Na Young ;

Bae, Hyun Ju ;

Min, Byung-Sun ;

Choi, Jae Sue .

ARCHIVES OF PHARMACAL RESEARCH, 2008, 31 (11) :1405-1412

[10] Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues [J].

Kamalakkannan, N. ;

Prince, P. Stanely Mainzen .

MOLECULAR AND CELLULAR BIOCHEMISTRY, 2006, 293 (1-2) :211-219

← 1 2 3 →